HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylurea

a VEGF receptor-2 tyrosine kinase inhibitor; structure in first source
Also Known As:
KRN 633; KRN-633; KRN633
Networked: 9 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Abe, Naomichi: 4 articles (08/2014 - 01/2010)
2. Ishii, Kunio: 4 articles (08/2014 - 01/2010)
3. Nagamitsu, Tohru: 4 articles (08/2014 - 01/2010)
4. Nakahara, Tsutomu: 4 articles (08/2014 - 01/2010)
5. Mori, Asami: 3 articles (08/2014 - 02/2013)
6. Sakamoto, Kenji: 3 articles (08/2014 - 02/2013)
7. Wada, Yoshiko: 3 articles (08/2013 - 01/2010)
8. Morita, Akane: 2 articles (08/2014 - 08/2013)
9. Ozaki, Hiromi: 2 articles (02/2013 - 01/2010)
10. Nakamura, Kazuhide: 2 articles (01/2006 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Pathologic Neovascularization
3. Weight Loss (Weight Reduction)
4. Fetal Growth Retardation (Intrauterine Growth Retardation)
5. Premature Birth (Birth, Premature)

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
3. Protein-Tyrosine Kinases (Tyrosine Kinase)
4. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
5. Tyrosine Kinase Inhibitors
6. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
7. Protein Kinase C
8. enzastaurin
9. Semaxinib (SU5416)

Related Therapies and Procedures

1. Withholding Treatment